Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Glob Health ; 12: 05038, 2022 Nov 08.
Artigo em Inglês | MEDLINE | ID: mdl-36342697

RESUMO

Background: We compared the probability of hospitalization and death caused by COVID-19 in patients with comorbidities during three periods defined for this study: first-wave (FW), interwave period (IP), and second-wave (SW) observed in Mexico City. Methods: In this registry-based study, we included individuals over 20 years of age. During the FW (symptomatic), the IP, and the SW (symptomatic and asymptomatic), participants were diagnosed using nasopharyngeal swabs. Symptomatic individuals with risk factors for serious disease or death were referred to the hospital. SARS-CoV-2 infection was defined by RT-qPCR in all hospitalized patients. All data were added to the SISVER database. Bayesian analysis and False Discovery Rate were used for further evaluation. Results: The study included 2 260 156 persons (mean age of 43.1 years). Of these, 8.6% suffered from DM, 11.6% arterial hypertension, and 9.7% obesity. Of the total, 666 694 persons tested positive (29.5%). Of the infected persons, a total of 85 587 (12.8%) were hospitalized: 24 023 in the FW; 16 935 in the IP, and 44 629 in the SW. Of the hospitalized patients, there were 42 979 deaths (50.2%), in the FW, 11 964 (49.8%), in the IP, 6794 (40.1%), and in the SW 24 221 (54.3%). The probability of death among individuals hospitalized with or without comorbidities increased consistently in all age groups. A significant increase in the Fatality Rate was observed in individuals with comorbidities (1.36E-19< = FDR< = 3.36E-2). A similar trend was also observed in individuals without comorbidities (1.03E-44< = FDR< = 5.58E-4). Conclusions: The data from this study show a considerable increase in the number of detected cases of infection between the FW and SW. In addition, 12.8% of those infected were hospitalized for severe COVID-19. A high mortality rate was observed among hospitalized patients (>50%). An age-dependent probability of death was observed with a positive trend in hospitalized patients with and without comorbidities.


Assuntos
COVID-19 , Humanos , Adulto , SARS-CoV-2 , Teorema de Bayes , México/epidemiologia , Hospitalização , Comorbidade , Surtos de Doenças
2.
Sci Total Environ ; 761: 143183, 2021 Mar 20.
Artigo em Inglês | MEDLINE | ID: mdl-33168247

RESUMO

During the COVID-19 pandemic lockdown, emissions of primary criteria pollutants in the Mexico City Metropolitan Area (MCMA) were substantially reduced, as in many other cities in the world. Unexpectedly, the daily average ozone concentration profile was practically indistinguishable from that of the past two years for the same time span in the calendar. So, we compared surface meteorology data, CO, NOx and O3 hourly concentrations in the MCMA from the ozone season (from March 1 to May 31) for the years 2018, 2019, and 2020. Also, TROPOMI satellite data on column count of CO, NO2 and HCHO, above a sparse grid of surface points in the MCMA, were also compared for March, April, and May 2020 with those from 2019. Population density used as a background variable to increase understanding of the observed differences allowed us to propose that reductions in NOx were so drastic that ozone formation moved rapidly from a VOC sensitive region towards a NOx sensitive region. The relevance of that unplanned policy provides impacts of contingent short-term emissions control actions during very high pollution episodes. Further analysis of these and other related data concerning VOC speciation and emissions patterns during the coronavirus lockdown may provide guidelines to enhance emission control policies in the post-COVID-19 times to come.


Assuntos
Poluentes Atmosféricos , Poluição do Ar , COVID-19 , Ozônio , Poluentes Atmosféricos/análise , Poluição do Ar/análise , Cidades , Controle de Doenças Transmissíveis , Monitoramento Ambiental , Humanos , México , Ozônio/análise , Pandemias , SARS-CoV-2
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...